Appetite hormone research tipped as Nobel Medicine favorite

Speculation ahead of Monday's Nobel Medicine announcement highlights appetite-regulating hormone research, likely referencing GLP-1 agonists behind weight-loss drugs. The claim is speculative and unconfirmed; the actual laureates remain unknown. If awarded, it would validate a transformative therapeutic class with major public-health and market implications.